AstraZeneca is to sell European rights to its cholesterol drug Crestor (rosuvastatin) to Germany’s Grunenthal. Crestor is a statin and at its peak generated annual revenues of more than $7 ...

the drug company repeated the safety and efficacy of the drug. Laura Bradbard, an FDA spokeswoman, said that Crestor is both effective and safe and that all the scientific evidence supports this ...

The Medication Adherence Pilot Program ... the generic version of Crestor®. Participation is automatic. The pilot program will run for up to five years. For more details, see this Military ...